Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 3,734 | 3,477 | 3,375 | 4,844 | 2,804 |
| Operating Income | -3,734 | -3,477 | -3,375 | -4,844 | -2,804 |
| Other Income | 3 | -41 | -54 | -266 | 5 |
| Pre-tax Income | -3,731 | -3,518 | -3,429 | -5,110 | -2,799 |
| Net Income Continuous | -3,731 | -3,518 | -3,429 | -5,110 | -2,799 |
| Net Income | $-3,731 | $-3,518 | $-3,429 | $-5,110 | $-2,799 |
| EPS Basic Total Ops | -0.17 | -0.17 | -0.17 | -0.27 | -0.14 |
| EPS Basic Continuous Ops | -0.16 | -0.16 | -0.16 | -0.25 | -0.15 |
| EPS Diluted Total Ops | -0.17 | -0.17 | -0.17 | -0.27 | -0.14 |
| EPS Diluted Continuous Ops | -0.16 | -0.16 | -0.16 | -0.25 | -0.15 |
| EBITDA(a) | $-3,732 | $-3,474 | $-3,372 | $-4,842 | $-2,801 |